Session » Infection-Related Rheumatic Disease Poster
-
Abstract Number: 2091
The High Dose Influenza Vaccine Increases Immune Protection in Both Adults and Elderly Seropositive RA Patients
-
Abstract Number: 2092
Efficacy and Safety of the Adjuvanted Recombinant Zoster Vaccine in Adults with Pre-existing Potential Immune Mediated Diseases: A Pooled Post-hoc Analysis on Two Parallel Randomized Trials
-
Abstract Number: 2093
Safety of Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su, Shingrix) Among Patients with Autoimmune Inflammatory Diseases
-
Abstract Number: 2094
Evaluation of Influenza and Pneumococcal Vaccination Rate in Patients with Rheumatoid Arthritis and Spondyloarthritis, and the Attitudes of Rheumatologists About Vaccination
-
Abstract Number: 2095
A Quality Improvement Intervention to Improve Influenza and Pneumococcal Vaccination Rates in Immunosuppressed Inflammatory Arthritis Outpatients
-
Abstract Number: 2096
An Intervention Bundle Increases Uptake of Influenza Vaccine by Rheumatoid Arthritis Patients
-
Abstract Number: 2097
Tuberculin Skin Test and Quantiferon®-TB Gold In-Tube Test for Latent Tuberculosis Before Biologic Treatments: Lower Agreement Rate in Spondyloarthropathies Compared to Rheumatoid Arthritis
-
Abstract Number: 2098
Distinctive Pattern of LTBI Screening Parameters in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) in Endemic Areas
-
Abstract Number: 2099
Comparison of Single and Dual Latent Tuberculosis Screening Strategies Before the Initiation of Biologic and Targeted Therapy in Rheumatological Patients in Hong Kong
-
Abstract Number: 2100
Screening for Hepatitis B Surface Antigen and Core Antibody Prior to Administration of Rituximab in Rheumatology Patients
-
Abstract Number: 2102
First-line Antiretroviral Therapy with Tenofovir Produces Deleterious Effects on Bone and an Increase in Proinflammatory Cytokines Expression After 12 Months of Treatment in Naïve HIV Patients
-
Abstract Number: 2103
Anti-TNF Therapy in Patients with HIV Infection
-
Abstract Number: 2104
Vasculitis in HIV-Infected Individuals: Making the Case for an Antigen Driven Process
-
Abstract Number: 2105
The Comparative Efficacy of Pneumocystis Pneumonia Prophylactic Regimens in Patients with Connective Tissue Diseases Receiving Prolonged High-dose Glucocorticoids
-
Abstract Number: 2106
Features of Pneumocystis Jirovecii Pneumonia in Juvenile Idiopathic Inflammatory Myopathy
-
Abstract Number: 2107
Comparison of the Management and Prognosis of Pneumonia in Patients with and Those Without Rheumatoid Arthritis Using the Japanese Diagnosis Procedure Combination Database
-
Abstract Number: 2108
Risk Factors for Pulmonary Nontuberculous Mycobacterial Disease in Rheumatoid Arthritis Patients
-
Abstract Number: 2109
Are Immunosuppressants a Risk Factor Associated with Mycobacterium Tuberculosis Infection in Colombian Patients with Systemic Lupus Erythematosus? A Case-control Study
-
Abstract Number: 2110
Invasive Aspergillosis in Rheumatologic Patients in Tertiary Care Hospital in Mexico
-
Abstract Number: 2111
Symptomatic Coccidioidomycosis Infections in Patients on Biologic Therapies
-
Abstract Number: 2112
Real Life Serious Infections in Patients with Chronic Inflammatory Arthritis on Treatment with TNF Inhibitors
-
Abstract Number: 2113
Biological Therapy Is Associated with Faster Recovery and Lower Frequency of Switch Treatment in Patients with Chikungunya Fever
-
Abstract Number: 2114
Risk Factors for Cytomegalovirus Infection in Patients with Autoimmune Diseases
-
Abstract Number: 2115
BK Polyomavirus Viremia and Viruria in Patients with Autoimmune Connective Tissue Diseases: Impact of Immunosuppressants
-
Abstract Number: 2116
Serious Infection in Patients with Systemic Lupus Erythematosus, Lupus Nephritis and Rheumatoid Arthritis Compared to the General Population: Incidence Rates Using Real-World Claims Data
-
Abstract Number: 2118
Efficacy and Safety of Tocilizumab Treatment for Anti–human T Lymphotropic Virus Type I Antibody–positive Rheumatoid Arthritis
-
Abstract Number: 2119
Impact of Day of Admission and Time to Diagnostic Arthrocentesis on Mortality and Other Outcomes in Septic Arthritis: A Nationwide Analysis
-
Abstract Number: 2120
No Evidence of an Increased Risk of Serious Infections Among 3 Classes of Biologics for Psoriasis or Psoriatic Arthritis: A Retrospective Real-World Cohort Study
-
Abstract Number: 2121
Hospitalization Trends for Bacterial Septic Arthritis in the United States from 1997 to 2014
-
Abstract Number: 2122
Outcomes and Risk Factors in Septic Arthritis with Underlying Rheumatic Conditions
-
Abstract Number: 2123
Clinical Features of Prosthetic Joint Infections in Patients with Rheumatic Diseases vs Osteoarthritis
-
Abstract Number: 2125
Rheumatic Fever in a Tertiary Medical Center – 25 Years of Follow Up
-
Abstract Number: 2126
Combined Detection of Cytokines and Biomarkers Improve the Diagnostic Performance of Bacteria Infection in Rheumatoid Arthritis
-
Abstract Number: 2127
Diagnosis of Inflammatory Rheumatic Diseases: Preliminary Approach by Urine Metabolomics